Arkolith/Insider Trading/COGT/Form 4

Fairmount Funds Management LLC

10% OwnerCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Feb 16, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 16, 2024Grant(A)1.2M$7.50$8.7M4.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 16, 2024Grant(A)2K$7500.00$11.3M2K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-016610) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML